JP7884535B2 - スパイクタンパク質の変異を有する重症急性呼吸器症候群コロナウイルス2(sars-cov-2)バリアントを検出するための組成物および方法 - Google Patents

スパイクタンパク質の変異を有する重症急性呼吸器症候群コロナウイルス2(sars-cov-2)バリアントを検出するための組成物および方法

Info

Publication number
JP7884535B2
JP7884535B2 JP2023556784A JP2023556784A JP7884535B2 JP 7884535 B2 JP7884535 B2 JP 7884535B2 JP 2023556784 A JP2023556784 A JP 2023556784A JP 2023556784 A JP2023556784 A JP 2023556784A JP 7884535 B2 JP7884535 B2 JP 7884535B2
Authority
JP
Japan
Prior art keywords
seq
oligonucleotide sequence
cov
sars
oligonucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023556784A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024510465A (ja
JP2024510465A5 (cg-RX-API-DMAC7.html
Inventor
アール.フォンテチャ マルセル
マンギプディ カリヤニ
マノハー チトラ
デイビッド サンティーニ クリストファー
スパイアー ユージーン
スン チンタオ
エリザベス イー ミッシェル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JP2024510465A publication Critical patent/JP2024510465A/ja
Publication of JP2024510465A5 publication Critical patent/JP2024510465A5/ja
Application granted granted Critical
Publication of JP7884535B2 publication Critical patent/JP7884535B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP2023556784A 2021-03-15 2022-03-14 スパイクタンパク質の変異を有する重症急性呼吸器症候群コロナウイルス2(sars-cov-2)バリアントを検出するための組成物および方法 Active JP7884535B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163161398P 2021-03-15 2021-03-15
US63/161,398 2021-03-15
US202163168718P 2021-03-31 2021-03-31
US63/168,718 2021-03-31
PCT/EP2022/056496 WO2022194756A2 (en) 2021-03-15 2022-03-14 Compositions and methods for detecting severe acute respiratory syndrome coronavirus 2 (sars-cov-2) variants having spike protein mutations

Publications (3)

Publication Number Publication Date
JP2024510465A JP2024510465A (ja) 2024-03-07
JP2024510465A5 JP2024510465A5 (cg-RX-API-DMAC7.html) 2025-01-23
JP7884535B2 true JP7884535B2 (ja) 2026-07-03

Family

ID=81326309

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023556784A Active JP7884535B2 (ja) 2021-03-15 2022-03-14 スパイクタンパク質の変異を有する重症急性呼吸器症候群コロナウイルス2(sars-cov-2)バリアントを検出するための組成物および方法

Country Status (4)

Country Link
US (1) US20220290221A1 (cg-RX-API-DMAC7.html)
EP (1) EP4308726A2 (cg-RX-API-DMAC7.html)
JP (1) JP7884535B2 (cg-RX-API-DMAC7.html)
WO (1) WO2022194756A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220042117A1 (en) * 2020-08-06 2022-02-10 Roche Molecular Systems, Inc. COMPOSITIONS AND METHODS FOR THE SIMULTANEOUS DETECTION OF INFLUENZA A, INFLUENZA B, AND SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
US20240409984A1 (en) * 2023-06-09 2024-12-12 Revvity Health Sciences, Inc. Methods for detecting mutations in target nucleic acids using dual probes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017518028A (ja) 2014-03-28 2017-07-06 シージーン アイエヌシー 相異なる検出温度を利用したターゲット核酸配列の検出
JP2018514202A (ja) 2015-04-17 2018-06-07 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 遺伝子融合体を検出するための多重pcr

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU596068B2 (en) 1983-02-22 1990-04-26 Syngene, Inc. Defined sequence single strand oligonucleotides incorporating reporter groups, process for the chemical synthesis thereof, and nucleosides useful in such synthesis
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4996143A (en) 1985-12-23 1991-02-26 Syngene, Inc. Fluorescent stokes shift probes for polynucleotide hybridization
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5035996A (en) 1989-06-01 1991-07-30 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
US5683896A (en) 1989-06-01 1997-11-04 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
EP1067134B1 (en) 1991-11-07 2004-07-28 Nanotronics, Inc. Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system
DE69739357D1 (de) 1996-06-04 2009-05-28 Univ Utah Res Found Überwachung der hybridisierung während pcr
EP1442794B1 (en) 1996-06-04 2006-03-29 University Of Utah Research Foundation System and method for carrying out and monitoring biological processes
JP3756313B2 (ja) 1997-03-07 2006-03-15 武 今西 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
DK0866071T3 (da) * 1997-03-20 2005-01-17 Hoffmann La Roche Modificerede primere
US6794499B2 (en) 1997-09-12 2004-09-21 Exiqon A/S Oligonucleotide analogues
WO2005092038A2 (en) * 2004-03-22 2005-10-06 The Johns Hopkins University Methods for the detection of nucleic acid differences
CA2624917C (en) 2005-10-05 2013-07-09 F. Hoffmann-La Roche Ag Non-fluorescent energy transfer
CA2890004A1 (en) * 2012-10-31 2014-05-08 Becton, Dickinson And Company Selective amplification and real-time pcr detection of rare mutations
US20150176060A1 (en) * 2013-12-20 2015-06-25 Roche Molecular Systems, Inc. Method For Coding Of Multiple PCR Reactions For Assay Recognition
CN107849606A (zh) * 2015-04-20 2018-03-27 尼欧基因组学实验室股份有限公司 提高下一代测序灵敏度的方法
WO2016172204A1 (en) * 2015-04-24 2016-10-27 Becton, Dickinson And Company Multiplex detection of vulvovaginal candidiasis, trichomoniasis and bacterial vaginosis
RU2674338C1 (ru) * 2017-10-09 2018-12-07 Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) Способ анализа соматических мутаций в генах BRAF, NRAS и KIT с использованием LNA-блокирующей мультиплексной ПЦР и последующей гибридизацией с олигонуклеотидным биологическим микрочипом (биочипом)
WO2021152181A1 (en) * 2020-01-30 2021-08-05 Biomedrex Ab Virus therapy
CN110982945B (zh) * 2020-03-04 2020-06-09 珠海丽珠试剂股份有限公司 一种检测2019新型冠状病毒的核酸组合物、试剂盒以及方法
US20210292820A1 (en) * 2020-03-20 2021-09-23 Applied Dna Sciences, Inc. Compositions and methods for detecting and treating sars-cov-2
WO2021202158A1 (en) * 2020-04-01 2021-10-07 President And Fellows Of Harvard College Nested rpa and competitive reference standard
CN112111597B (zh) * 2020-04-28 2023-07-21 安徽同科生物科技有限公司 一种免核酸提取快速检测新型冠状病毒2019-nCoV核酸的荧光PCR试剂盒
CN111254228B (zh) * 2020-05-06 2020-09-11 上海思路迪医学检验所有限公司 一种检测新型冠状病毒和流感病毒的试剂盒
CN111560478B (zh) * 2020-05-27 2020-11-13 广州凯普医药科技有限公司 一种一步法反转录PCR结合Sanger测序检测新型冠状病毒的试剂盒
CN111534643B (zh) * 2020-07-10 2020-10-09 上海科技大学 一种检测呼吸道病原的核酸的试剂盒、检测方法及应用
WO2022020393A1 (en) * 2020-07-20 2022-01-27 Mammoth Biosciences, Inc. High-throughput single-chamber programmable nuclease assay
WO2022044011A1 (en) * 2020-08-25 2022-03-03 B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University Oligonucleotides and methods of using same
CN113637798A (zh) * 2021-08-09 2021-11-12 南昌大学 检测新冠病毒Alpha毒株S基因Δ69/70HV缺失突变位点的引物、探针及其应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017518028A (ja) 2014-03-28 2017-07-06 シージーン アイエヌシー 相異なる検出温度を利用したターゲット核酸配列の検出
JP2018514202A (ja) 2015-04-17 2018-06-07 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 遺伝子融合体を検出するための多重pcr

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Dominik Norz et al.,Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with build-in screening functionality for DelHV69/70- and N501Y variants such as B.1.1.7,medRxiv,2021年02月18日,https://www.medrxiv.org/content/10.1101/2021.02.12.21251614v1
Nancy J Schoenbrunner et al.,Covalent modification of primers improves PCR amplification specificity and yield,Biology Methods and Protocols,2017年11月21日,2017,bpx011

Also Published As

Publication number Publication date
JP2024510465A (ja) 2024-03-07
WO2022194756A2 (en) 2022-09-22
US20220290221A1 (en) 2022-09-15
EP4308726A2 (en) 2024-01-24
WO2022194756A3 (en) 2022-12-01

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250114

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250114

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20251217

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260324

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260616

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260623

R150 Certificate of patent or registration of utility model

Ref document number: 7884535

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150